Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[11C]MODAG-005 PET Imaging in Parkinson's Disease and Multiple System Atrophy
NCT07640542Phase 1Recruiting
- Sponsor
- MODAG
- Start
- Jul 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of [11C]MODAG-005 in Parkinson's disease (PD) and multiple system atrophy (MSA), sponsored by MODAG. Primary endpoint: Safety and Tolerability. Started Jul 2026; status: recruiting.
02
Drugs
[11C]MODAG-005
03
Conditions
Parkinson's disease (PD)multiple system atrophy (MSA)
Beyond the preview
Go deeper on NCT07640542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07640542.